|
Volumn 1, Issue 2, 2000, Pages 97-102
|
The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ENZYME INHIBITOR;
FINASTERIDE;
CARDIOVASCULAR FUNCTION;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
DRUG COMBINATION;
DRUG EFFECT;
HUMAN;
IMPOTENCE;
MALE;
PATHOLOGY;
PATHOPHYSIOLOGY;
PROSTATE HYPERTROPHY;
REVIEW;
ADRENERGIC ALPHA-ANTAGONISTS;
CARDIOVASCULAR PHYSIOLOGY;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
FINASTERIDE;
HUMANS;
IMPOTENCE;
MALE;
PROSTATIC HYPERPLASIA;
|
EID: 0034256511
PISSN: 15272737
EISSN: None
Source Type: Journal
DOI: 10.1007/s11934-000-0043-z Document Type: Review |
Times cited : (8)
|
References (40)
|